Sort by
Refine Your Search
-
. Mechanobiology in aging in the musculoskeletal system or the cardiovascular system: this area focuses on the application of mechanobiology technology and discovery to the aging research. 2. Immunomechanobiology
-
Disorder is a collaboration between CDD training faculty based in the Departments of Pharmaceutical Sciences and Chemistry and Chemical Biology at Northeastern University in Boston, MA (Drs. Raymond Booth
-
diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause
-
diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause
-
of specific proteins in a cancer cell’s nucleus with SINE technology. Our primary focus is on developing novel drugs which we hope will help treat patients with certain blood cancers or solid tumor malignancies
-
. Andrew Orr-Skirvin, PharmD, BCOP Clinical Professor, School of Pharmacy Chair, Department of Pharmacy & Health System Sciences Director of Pharmaceutical Industry Fellowship Program 360 Huntington Ave
-
, launch readiness, advisory board support, congress strategy, scientific training and educational initiatives Field Medical Affairs (Medical Science Liaison) Sample projects: Scientific engagement with
-
About the Opportunity About the Opportunity : The Bouve College of Health Sciences is looking to hire a Post-doctoral Fellow (Medicinal Chemistry and Drug Discovery) in the Department
-
stakeholders Foster collaboration and leadership skills through cross-functional projects Partner with Medical Directors /Health Economics Directors/Publications to contribute to scientific plans and materials
-
opportunity to work collaboratively with other functional areas within Ironwood including clinical development, medical scientific affairs, program management, data sciences, quality and compliance, nonclinical